BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 8914177)

  • 1. Peritoneal dialysis kinetic modeling: validation in a multicenter clinical study.
    Vonesh EF; Burkart J; McMurray SD; Williams PF
    Perit Dial Int; 1996; 16(5):471-81. PubMed ID: 8914177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multinational clinical validation study of PD ADEQUEST 2.0. PD ADEQUEST International Study Group.
    Vonesh EF; Story KO; O'Neill WT
    Perit Dial Int; 1999; 19(6):556-71. PubMed ID: 10641777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of the PD Adequest mathematical model in pediatric patients on chronic peritoneal dialysis.
    Verrina E; Amici G; Perfumo F; Trivelli A; Canepa A; Gusmano R
    Perit Dial Int; 1998; 18(3):322-8. PubMed ID: 9663898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of PD Adequest 2.0 for pediatric dialysis patients.
    Warady BA; Watkins SL; Fivush BA; Andreoli SP; Salusky I; Kohaut EC; Vonesh EF
    Pediatr Nephrol; 2001 Mar; 16(3):205-11. PubMed ID: 11322365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Validation of a Peritoneal Dialysis Prescription Model in the PatientOnLine Software.
    Hodzic E; Rasic S; Klein C; Covic A; Unsal A; Cunquero JM; Prischl FC; Gauly A; Kalicki RM; Uehlinger DE
    Artif Organs; 2016 Feb; 40(2):144-52. PubMed ID: 26147618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volume-Based Peritoneal Dialysis Prescription Guide to Achieve Adequacy Targets.
    Akonur A; Firanek CA; Gellens ME; Hutchcraft AM; Kathuria P; Sloand JA
    Perit Dial Int; 2016; 36(2):188-95. PubMed ID: 26293841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic Modeling of Incremental Ambulatory Peritoneal Dialysis Exchanges.
    Guest S; Leypoldt JK; Cassin M; Schreiber M
    Perit Dial Int; 2017; 37(2):205-211. PubMed ID: 28096442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creatinine clearance in continuous peritoneal dialysis: dialysis dose required for a minimal acceptable level.
    Tzamaloukas AH; Murata GH; Malhotra D; Fox L; Goldman RS; Avasthi PS
    Perit Dial Int; 1996; 16(1):41-7. PubMed ID: 8616171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical validation of PD Adequest software: modeling error assessment.
    Amici G; Mastrosimone S; Da Rin G; Bocci C; Bonadonna A
    Perit Dial Int; 1998; 18(3):317-21. PubMed ID: 9663897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal urea and creatinine clearances in continuous peritoneal dialysis patients with different types of peritoneal solute transport.
    Tzamaloukas AH; Murata GH; Piraino B; Rao P; Bernardini J; Malhotra D; Oreopoulos DG
    Kidney Int; 1998 May; 53(5):1405-11. PubMed ID: 9573559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing the dialysis volume and frequency in a fixed period of time in CPD patients: the effect on Kpt/V and creatinine clearance.
    Juergensen PH; Murphy AL; Kliger AS; Finkelstein FO
    Perit Dial Int; 2002; 22(6):693-7. PubMed ID: 12556071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adequacy of dialysis in automated peritoneal dialysis: a clinical experience.
    Fernández Rodríguez AM; Vega Díaz N; Palop Cubillo L; Baamonde Laborda E; Morales Umpierrez A; Pérez Borges P; Navarro Zurita M; Plaza Toledano C
    Perit Dial Int; 1997; 17(5):442-8. PubMed ID: 9358525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous peritoneal dialysis in heavyweight individuals: urea and creatinine clearances.
    Tzamaloukas AH; Dimitriadis A; Murata GH; Nicolopoulou N; Malhotra D; Balaskas EV; Kakavas J; Antoniou S; Dombros NV; Batzili E; Voudiklari S
    Perit Dial Int; 1996; 16(3):302-6. PubMed ID: 8761545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urea kinetic analysis of automated peritoneal dialysis allows calculation of a CAPD-equivalent Kt/V(urea).
    Schurman SJ; Shoemaker LR; Warady BA
    Kidney Int; 2000 Sep; 58(3):1318-24. PubMed ID: 10972696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of clearances on tidal peritoneal dialysis and intermittent peritoneal dialysis.
    Piraino B; Bender F; Bernardini J
    Perit Dial Int; 1994; 14(2):145-8. PubMed ID: 8043667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of peritoneal permeability and residual renal function on PD prescription.
    Harty J; Gokal R
    Perit Dial Int; 1996; 16 Suppl 1():S147-52. PubMed ID: 8728182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body surface area limitations in achieving adequate therapy in peritoneal dialysis patients.
    Rocco MV
    Perit Dial Int; 1996; 16(6):617-22. PubMed ID: 8981531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of dialysis dose by measured clearance versus extrapolated data.
    Burkart JM; Jordan JR; Rocco MV
    Perit Dial Int; 1993; 13(3):184-8. PubMed ID: 8369346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of peritoneal mass transport by three-pore model in children.
    Schaefer F; Haraldsson B; Haas S; Simkova E; Feber J; Mehls O
    Kidney Int; 1998 Oct; 54(4):1372-9. PubMed ID: 9767558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics and dosing predictions for daily haemofiltration.
    Leypoldt JK; Jaber BL; Lysaght MJ; McCarthy JT; Moran J
    Nephrol Dial Transplant; 2003 Apr; 18(4):769-76. PubMed ID: 12637647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.